Ryan Allway March 28th, 2022 News, Top News CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / March 28, 2022 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) (“WGG” or the “Company”), a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research is pleased to share the following update: Medspresso™ and Liviana™ are... Read more
M2Bio Sciences (OTC: $WUHN) Launches Mental Illness Drug Discovery Company Neurai Life Sciences.
January 19, 2022
Ryan Allway January 19th, 2022 CAPE TOWN, SA / ACCESSWIRE / January 19, 2022 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) (“WGG” or the “Company”), a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research is pleased to share the following update: Wuhan General Group, Inc./M2Bio Sciences,... Read more
Ryan Allway August 5th, 2021 Psychedelics CAPE TOWN, SA / ACCESSWIRE / August 5, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) (“Wuhan” or the “Company”), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research, is pleased to announce the following corporate update: The research team funded... Read more
